Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Burden of New Hospitalization for Heart Failure: A Population-Based Investigation from Italy
2014
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Survival of Patients with Chronic Heart Failure in the Community: A Systematic Review and Meta-Analysis
2019
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
ESUR prostate MR guidelines 2012
2012 Standout
Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis
2020
The Lifespan and Turnover of Microglia in the Human Brain
2017
Application of Metabolomics to Cardiovascular Biomarker and Pathway Discovery
2008
Molecular imaging in drug development
2008 Standout
Desmin-related myopathy: clinical, electrophysiological, radiological, neuropathological and genetic studies
2004
Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical Trials
1997
Skeletal muscle involvement in cardiomyopathies
2013
Metal–organic framework composites
2014 Standout
Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure
1998
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Experience and modification update for the minimally invasive Nuss technique for pectus excavatum repair in 303 patients
2002 Standout
Pericardial Complications of Cardiac Surgery: Emphasis on the Diagnostic Role of Echocardiography
1992
Glucagon-Like Peptide-1 Limits Myocardial Stunning following Brief Coronary Occlusion and Reperfusion in Conscious Canines
2004
Glucagon-Like Peptide-1 Infusion Improves Left Ventricular Ejection Fraction and Functional Status in Patients With Chronic Heart Failure
2006
Macrophages in immunoregulation and therapeutics
2023 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
The biology of incretin hormones
2006 Standout
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
2018
Systemic sclerosis
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
β-adrenergic blockade in chronic heart failure: Principles, progress, and practice
1998
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
2011
Magnetic resonance and fluorescence based molecular imaging technologies
2005
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
2011
Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions
2002
Direct Effects of Glucagon-Like Peptide-1 on Myocardial Contractility and Glucose Uptake in Normal and Postischemic Isolated Rat Hearts
2006
Dynamic magnetic resonance imaging of tumor perfusion
2004
Dendrimers in biomedical applications—reflections on the field
2005 Standout
GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects
2009
Positive effects of polyethylene glycol conjugation to generation‐4 polyamidoamine dendrimers as macromolecular MR contrast agents
2001
Biology of Incretins: GLP-1 and GIP
2007 Standout
Exosomes: biogenesis, biologic function and clinical potential
2019 Standout
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Micro‐MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: Reference to pharmacokinetic properties of dendrimer‐based MR contrast agents
2001
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Systemic amyloidosis
2015 Standout
Magnetic resonance relaxation properties of superparamagnetic particles
2009
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving β-blockers
2004
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
The Physiology of Glucagon-like Peptide 1
2007 Standout
Myocardial Reperfusion Injury
2007 Standout
Echocardiographic Indexes for the Non-Invasive Evaluation of Pulmonary Hemodynamics
2010
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
1999 Standout
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)
2005
Metabolite profiles and the risk of developing diabetes
2011 Standout
Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
1994
Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy
2005
Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice
2011
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
The dawning era of polymer therapeutics
2003 Standout
Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
2009
Complications of Percutaneous Pericardiocentesis under Fluoroscopic Guidance
1992
Effect of beta-blocker therapy on functional status in patients with heart failure - A meta-analysis
2005
Role of Exosomes in Myocardial Remodeling
2014
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
2004 Standout
Cardiovascular Biology of the Incretin System
2012
Overview of transition metal and lanthanide complexes as diagnostic tools
1999
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
THE GENETIC BASIS FOR CARDIAC REMODELING
2005
International consensus statement on the peri‐operative management of anaemia and iron deficiency
2016 Standout
Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion
2004
GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
2009
Alterations in dynamic heart rate control in the β1-adrenergic receptor knockout mouse
1998 StandoutNobel
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Long‐term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent
2004
Negative Chronotropic Effect of β-Blockade Therapy Reduces Myocardial Oxygen Expenditure for Nonmechanical Work
1996
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2001 Standout
INSIGHTS FROM IN VIVO MODIFICATION OF ADRENERGIC RECEPTOR GENE EXPRESSION
1998 StandoutNobel
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
Long-circulating blood pool imaging agents
1995
Glucagon-like Peptide 1 Can Directly Protect the Heart Against Ischemia/Reperfusion Injury
2005
Works of Gerhard Wikström being referenced
Recurrent Heart Failure Hospitalizations Increase the Risk of Cardiovascular and All-Cause Mortality in Patients with Heart Failure in Sweden: A Real-World Study
2021
Life Science Applications Utilizing Radiocarbon Tracing
2013
In Vivo Visualization of Amyloid Deposits in the Heart with 11C-PIB and PET
2012
The burden of preserved ejection fraction heart failure in a real-world Swedish patient population
2013
Lack of evidence of stimulatory autoantibodies to platelet‐derived growth factor receptor in patients with systemic sclerosis
2009
Ischaemic preconditioning is related to decreasing levels of extracellular adenosine that may be metabolically useful in the at‐risk myocardium: an experimental study in the pig
2009
Glucagon-like peptide-1 (7–36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium
2003
First-Pass Myocardial Perfusion MR Imaging with Outer-Volume Suppression and the Intravascular Contrast Agent NC100150 Injection: Preliminary Results in Eight Patients
2001
In and Ex Vivo MR Evaluation of Acute Myocardial Ischemia in Pigs by Determining R1 in Steady State After the Administration of the Intravascular Contrast Agent NC100150 Injection
2004
Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment
1994
<p>Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden</p>
2019
Healthcare resource utilisation and costs associated with a heart failure diagnosis: a retrospective, population-based cohort study in Sweden
2021
Effects of administration of iron isomaltoside 1000 in patients with chronic heart failure. A pilot study
2010
Pericardial Effusion and Pericardial Compartments after Open Heart Surgery
1990
Right ventricular myocardial isovolumic relaxation time and pulmonary pressure
2005
Double-Contrast MR Imaging of Reperfused Porcine Myocardial Infarction
1996
Energy‐related metabolites during and after induced myocardial infarction with special emphasis on the reperfusion injury after extracorporeal circulation
2001
Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q
1999
Resource Utilization and Cost of Heart Failure associated with Reduced Ejection Fraction in Swedish Patients
2012
Mr Imaging of Acute Myocardial Infarction in Pigs Using Gd-DTPA-Labeled Dextran
1992
A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension
2017
Mr Imaging of Acute Myocardial Infarction in Pigs Using GD-Dtpa-Labeled Dextran
1992